Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent gram-positive clinical isolates
- 31 May 2004
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 49 (1), 63-65
- https://doi.org/10.1016/j.diagmicrobio.2003.12.005
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitorInternational Journal of Antimicrobial Agents, 2003
- Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolideJournal of Antimicrobial Chemotherapy, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitor.Journal of Antimicrobial Chemotherapy, 2002
- N-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial ActivityAntimicrobial Agents and Chemotherapy, 2002
- Overcoming Bacterial Resistance by Dual Target Inhibition: The Case of StreptograminsCurrent Drug Targets - Infectious Disorders, 2001
- Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance DevelopmentAntimicrobial Agents and Chemotherapy, 2001
- Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase InhibitorAntimicrobial Agents and Chemotherapy, 2001
- Peptide Deformylase in Staphylococcus aureus : Resistance to Inhibition Is Mediated by Mutations in the Formyltransferase GeneAntimicrobial Agents and Chemotherapy, 2000
- On the release of the formyl group from nascent proteinJournal of Molecular Biology, 1968